What it costs

Peptide Pricing and Cost Analysis

Prices normalised to cost per milligram and adjusted for purity, so vials of different sizes and grades can be compared directly.

In short

Headline prices are close to meaningless in this market because vial sizes, concentrations and purity all differ between suppliers. We index public vendor listings and normalise everything to price per milligram, then adjust for purity, because that is the only figure that lets you compare two offers honestly.

Below is how that calculation works, what actually drives the cost of a peptide, and the ranges we currently see across the market.

Why headline prices mislead

A vendor quoting $95 a vial and a vendor quoting $110 a vial are not necessarily offering you the same thing, or even a comparable thing. Vial sizes range from 2 mg to 50 mg, concentrations vary, and purity is rarely stated on the product page at all. The number on the listing answers a question nobody is actually asking.

The first correction is simple arithmetic: divide the price by the milligrams in the vial. A 20 mg vial at $40 costs $2.00 per milligram. A 10 mg vial at $25 looks cheaper on the shelf but works out to $2.50 per milligram, twenty-five percent more expensive. Vial size alone can reverse which offer is better.

Price per effective milligram

The second correction is the one almost nobody makes. If purity varies between two products, you are paying for the impurity fraction as well, so the honest figure is cost per effective milligram: price divided by the mass that is actually the target sequence.

A worked example from our retatrutide indexing shows how far this can move a decision. A 10 mg vial at $110 with 99.4 percent purity comes to $1.11 per effective milligram. A cheaper vial at $95 with 91 percent purity comes to $1.04 per effective milligram, so it is still nominally the better buy, but it carries a nine percent impurity load into whatever you do with it.

Whether that trade is worth making is a judgement about the work, not about the price. The point is that a per-milligram figure hides it entirely, and a per-effective-milligram figure puts it in front of you.

What actually drives the cost

Peptide pricing is not arbitrary, even where it looks it. Four things move it:

  • Sequence length and complexity. Each additional amino acid is another coupling step with its own yield loss. A fifteen-residue peptide like BPC-157 is cheap to make; a long triple agonist is not.
  • Purification depth. Getting from 95 to 99 percent purity costs disproportionately more than getting to 95 in the first place, because the last few percent are the hardest to remove.
  • Analytical verification. Independent HPLC and mass spectrometry on every batch is a real per-batch cost. Vendors who skip it are genuinely cheaper to run.
  • Grade and intent. A certified analytical reference standard and bulk research material are different products sold for different purposes, and the price gap between them is legitimate rather than suspicious.

This is why a low price is not automatically a red flag, and a high price is certainly not a guarantee. What matters is whether the price is explained by something you can verify.

Ranges we currently see

Figures below come from our own indexing of public vendor listings. Prices move often, so treat them as orientation rather than as quotes.

CompoundObserved rangeWhat the spread tells you
Retatrutide~$300 per 1 mg reference standard, down to ~$375 per 30 mg vialThe widest spread we track. Grade differences explain part of it, loose labelling explains the rest.
TB-500$0.50 to $12.40 per mg; 5 mg vial $60–70 at established suppliersA twenty-five fold spread with little correlation to the analytical data supplied.
BPC-157~$34.99 per 5 mg vialCheap and high volume, which shifts the risk from impurity toward under-filling and substitution.
GHK-CuAverage ~$9.91 per unit, full range $0.07 to $89At the low end shipping of $15–35 can exceed the price of the material itself.
NAD+~$2.00 to $2.50 per mg depending on vial sizeA clean illustration of vial size reversing which listing is cheaper.

When a low price is worth a second look

The useful way to think about a suspiciously cheap listing is to price the alternative. Independently re-testing a batch through a third-party laboratory typically runs $300 to $500 per sample. If the saving on the vial is $15 and the doubt it creates would cost $400 to resolve, the saving is not real.

That framing also tells you when cheap is fine. If a vendor publishes a current, batch-matched certificate from a named laboratory, a low price is just a low price.

Compare landed cost, not catalogue price

Shipping is frequently structured to move behaviour rather than to cover cost. Charges of $15 to $35 per order are normal, and free-shipping thresholds around $150 quietly push buyers toward larger orders than they need, which means committing more money to a single unverified batch.

Add shipping, any payment surcharge and, where relevant, the cost of your own verification before comparing two vendors. The ranking changes more often than you would expect.

Prices on this page are indexed from public vendor listings and change frequently. Nothing here is medical advice or a recommendation to purchase any compound. See our editorial policy for how we index and correct this data.

Pricing analysis